SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001681871-17-000011
Filing Date
2017-03-03
Accepted
2017-03-03 18:45:05
Documents
2
Period of Report
2016-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2645
2 POWER OF ATTORNEY poaseldessouky.txt EX-24 3458
  Complete submission text file 0001681871-17-000011.txt   7667
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 ROSZEL ROAD PRINCETON NJ 08540
Business Address
Eldessouky Sam (Reporting) CIK: 0001558676 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 17665968